Research Article

Prevalence of Anxiety and Depression in Prostate Cancer Patients and Their Spouses: An Unaddressed Reality

Table 6

Relationship between primary treatment and stage of the disease with the possibility of the test being pathological.

HTRPRTASSTUTLocal.L. adv. MtxCRPC

MAX-PC5/49 (10.2%)10/99 (10.1%)3/16 (18.75%)2/20 (10%)0.725/41 (12.2%)15/143 (10.5%)0.3811/117 (10.2%)3/33 (9.09%)5/24 (20.8%)1/10 (10%)0.42
HADS anxiety patient8/49 (16.3%)13/99 (13.13%)3/16 (18.7%)2/20 (10%) 0.845/41 (12.2%)21/143 (14.7%)0.6915/117 (12.8%)6/33 (18.8%)4/24 (16.6%)1/10 (10%)0.83
HADS depression patient4/49 (8.16%)6/99 (6.06%)2/16 (12.5%)1/20 (5%)0.783/41 (7.3%)10/143 (6.9%)0.945/117 (4.2%)5/33 (15.1%)2/24 (8.3%)1/10 (10%)0.18
PHQ patient5/49 (10.2%)8/99 (8.08%)2/16 (12.5%)2/20 (10%)0.935/41 (12.2%)12/143 (8.4%)0.417/117 (5.9%)4/33 (12.1%)4/24 (16.6%)2/10 (20%)0.19

() Pearson’s chi-square. ST: sequential treatment; UT: unique treatment; Local.: Localized PC; L. adv.: Locally advanced PC; MTX: metastatic PC; CRPC: castration resistant PC.